TRAF3 Is Required for NF-&#954;B Pathway Activation Mediated by HTLV Tax Proteins by Fochi, Stefania et al.
fmicb-10-01302 June 10, 2019 Time: 13:26 # 1
ORIGINAL RESEARCH
published: 12 June 2019
doi: 10.3389/fmicb.2019.01302
Edited by:
Louis M. Mansky,
University of Minnesota Twin Cities,
United States
Reviewed by:
Edward Harhaj,
Penn State Milton S. Hershey Medical
Center, United States
Jean-Marie Peloponese,
UMR9004 Institut de Recherche en
Infectiologie de Montpellier (IRIM),
France
*Correspondence:
Maria Grazia Romanelli
mariagrazia.romanelli@univr.it
Specialty section:
This article was submitted to
Virology,
a section of the journal
Frontiers in Microbiology
Received: 28 February 2019
Accepted: 24 May 2019
Published: 12 June 2019
Citation:
Fochi S, Bergamo E, Serena M,
Mutascio S, Journo C, Mahieux R,
Ciminale V, Bertazzoni U, Zipeto D
and Romanelli MG (2019) TRAF3 Is
Required for NF-κB Pathway
Activation Mediated by HTLV Tax
Proteins. Front. Microbiol. 10:1302.
doi: 10.3389/fmicb.2019.01302
TRAF3 Is Required for NF-κB
Pathway Activation Mediated by
HTLV Tax Proteins
Stefania Fochi1, Elisa Bergamo1, Michela Serena1, Simona Mutascio1, Chloé Journo2,
Renaud Mahieux2, Vincenzo Ciminale3,4, Umberto Bertazzoni1, Donato Zipeto1 and
Maria Grazia Romanelli1*
1 Department of Neurosciences, Biomedicine and Movement Sciences, Section of Biology and Genetics, University
of Verona, Verona, Italy, 2 Retroviral Oncogenesis Laboratory, Centre International de Recherche en Infectiologie (CIRI),
INSERM U1111 – Université Claude Bernard Lyon 1, CNRS, Equipe Labellisée “Fondation pour la Recherche Médicale”,
UMR5308, Ecole Normale Supérieure de Lyon, Université Lyon, Lyon, France, 3 Department of Surgery, Oncology
and Gastroenterology, University of Padua, Padua, Italy, 4 Veneto Institute of Oncology IOV – IRCCS, Padua, Italy
Human T-cell leukemia viruses type 1 (HTLV-1) and type 2 (HTLV-2) share a common
genome organization and expression strategy but have distinct pathological properties.
HTLV-1 is the etiological agent of Adult T-cell Leukemia (ATL) and of HTLV-1-Associated
Myelopathy/Tropical Spastic Paraparesis (HAM/TSP), whereas HTLV-2 does not cause
hematological disorders and is only sporadically associated with cases of subacute
myelopathy. Both HTLV genomes encode two regulatory proteins that play a pivotal
role in pathogenesis: the transactivating Tax-1 and Tax-2 proteins and the antisense
proteins HBZ and APH-2, respectively. We recently reported that Tax-1 and Tax-2 form
complexes with the TNF-receptor associated factor 3, TRAF3, a negative regulator
of the non-canonical NF-κB pathway. The NF-κB pathway is constitutively activated
by the Tax proteins, whereas it is inhibited by HBZ and APH-2. The antagonistic
effects of Tax and antisense proteins on NF-κB activation have not yet been fully
clarified. Here, we investigated the effect of TRAF3 interaction with HTLV regulatory
proteins and in particular its consequence on the subcellular distribution of the effector
p65/RelA protein. We demonstrated that Tax-1 and Tax-2 efficiency on NF-κB activation
is impaired in TRAF3 deficient cells obtained by CRISPR/Cas9 editing. We also found
that APH-2 is more effective than HBZ in preventing Tax-dependent NF-κB activation.
We further observed that TRAF3 co-localizes with Tax-2 and APH-2 in cytoplasmic
complexes together with NF-κB essential modulator NEMO and TAB2, differently from
HBZ and TRAF3. These results contribute to untangle the mechanism of NF-κB
inhibition by HBZ and APH-2, highlighting the different role of the HTLV-1 and HTLV-2
regulatory proteins in the NF-κB activation.
Keywords: HTLV, NF-κB, Tax, HBZ, APH-2, TRAF3
INTRODUCTION
Human T-cell leukemia virus type 1 (HTLV-1) was the first human retrovirus discovered. It is
estimated that 10–20 million people are infected worldwide by this oncogenic virus. The majority
of infected carriers remain asymptomatic, but 5–10% of infected subjects are at risk of developing
either Adult T-cell Leukemia (ATL), a highly aggressive peripheral T-cell malignancy, or a chronic
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neurodegenerative disorder called HTLV-1-Associated
Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) (Kannian
and Green, 2010; Ishitsuka and Tamura, 2014; Bangham
et al., 2015). HTLV-1 is genetically related to HTLV type 2
(HTLV-2), which is associated with lymphocyte proliferation
and rare cases of subacute myelopathy but does not cause
hematological disorders (Araujo and Hall, 2004; Bartman et al.,
2008). The difference in the pathobiology of HTLV-1 and
HTLV-2 might provide important clues to further understand
the mechanisms leading to their distinct clinical outcomes.
HTLV-1 and HTLV-2 express the transactivating proteins Tax-1
and Tax-2, respectively, which can immortalize human CD4+
T-cell (Cheng et al., 2012; Ciminale et al., 2014; Ma et al., 2016).
Both Tax proteins activate viral RNA transcription from the
LTR promoter (Journo et al., 2009), interact and modulate the
expression of a wide range of cellular proteins and deregulate
multiple cellular pathways (Romanelli et al., 2013). Among them,
Tax proteins induce the hyper-activation of NF-κB transcription
factors, thus altering the control mechanisms of cell proliferation
and survival (Harhaj et al., 2007; Kfoury et al., 2012; Fochi
et al., 2018). The mechanism of Tax-mediated NF-κB activation
has been intensively studied in the past years showing that
Tax-1 interacts with the regulatory IKK-γ subunit of IκB kinase
complex, also known as NF-κB essential modulator (NEMO).
This interaction results in the constitutive activation of IKKα
and IKKβ, that leads to degradation of the inhibitor IκB and
activation of the canonical NF-κB pathway (Xiao et al., 2006;
Sun, 2017). Several other factors involved in the persistent
activation of the NF-κB pathway have been found to interact
with Tax-1, including TAB2 (TAK1 binding protein 2), TAX1BP
(Tax1 binding protein 1), NRP/Optineurin, TRAF6 and CADM1
(cell adhesion molecule 1) (Avesani et al., 2010; Journo et al.,
2013; Pujari et al., 2015). It has been demonstrated that persistent
NF-κB activation by Tax-1 induces cell senescence (Kuo and
Giam, 2006; Zhi et al., 2011) and this effect may be counteracted
by the expression of the HTLV-1 antisense protein HTLV-1
bZIP factor (HBZ). HBZ is an inhibitor of the activation of
5′LTR promoter and of Tax-1-mediated transcription. HBZ is
constitutively expressed in most ATL cases and enhances the
proliferation of T-cells in vitro and in vivo (Satou et al., 2006).
The combined action of Tax-1 and HBZ is considered relevant
for the proliferation of HTLV-1 infected cells and persistent
infection (Barbeau et al., 2013; Zhao, 2016). Several studies have
demonstrated that HBZ and Tax-1 exert opposite functions in
the deregulation of cellular signaling pathways that may help the
virus to escape from immune surveillance (Gaudray et al., 2002;
Zhao, 2016; Bangham and Matsuoka, 2017; Baratella et al., 2017;
Karimi et al., 2017). HBZ selectively inhibits the canonical NF-κB
pathway activated by Tax-1 together with the host transcription
factor p65, by repressing the p65 ability to bind DNA (Zhao
et al., 2009). Furthermore, HBZ reduces p65 acetylation and
enhances its degradation through the PDLIM2 E3 ubiquitin
ligase, resulting in the reduction of the expression of several NF-
κB target genes (Zhao et al., 2009; Wurm et al., 2012). Recently,
Ma et al. (2017) have demonstrated that HBZ-mediated NF-κB
inhibition contributes to the suppression of cyclin D1 gene
expression, favoring the G1/S phase transition of the cell cycle.
HTLV-2 also expresses an antisense transcript, encoding
APH-2 (antisense protein of HTLV-2) (Halin et al., 2009), which
is widely expressed in vivo (Douceron et al., 2012). Unlike
Tax-1 and Tax-2, which show a high degree of conservation,
APH-2 shows less than 30% similarity to HBZ and does not
contain a conventional basic leucine zipper domain. APH-2
is likewise able to inhibit Tax-2-mediated viral transcription
by interacting with CREB (Halin et al., 2009; Yin et al.,
2012), but its repressive activity is weaker compared to HBZ.
It was recently reported that APH-2, like HBZ, represses
p65 transactivation. However, APH-2 does not reduce the
level of p65 expression nor induces its ubiquitination (Panfil
et al., 2016). It is not yet established whether APH-2 inhibits
Tax-2-mediated NF-κB activation. Of note, while both Tax-1 and
Tax-2 activate the canonical NF-κB pathway, only Tax-1 activates
the non-canonical one by recruiting NEMO and IKKα to p100
and promoting the release of p52/RelB active heterodimers
into the nucleus (Shoji et al., 2009; Motai et al., 2016). These
different mechanisms still need to be adequately addressed. We
have recently demonstrated that both Tax-1 and Tax-2 interact
with the TNF-receptor associated factor 3 (TRAF3), an adaptor
protein that participates in the crosstalk between the type I
interferon (IFN-I), the mitogen-activated protein kinase (MAPK)
and the NF-κB pathways (Diani et al., 2015). TRAF3 positively
regulates IFN-I production, while it inhibits the MAPK pathway
and the non-canonical NF-κB pathway (Häcker et al., 2011).
TRAF3 is a component of a multiprotein complex containing
TRAF2 and the cellular inhibitor of apoptosis proteins cIAP1
and cIAP2, which restrict the activation of the non-canonical
NF-κB pathway. TRAF3 also participates in the degradation of
the alternative NF-κB inducing kinase NIK (Hauer et al., 2005;
Vallabhapurapu et al., 2008; Zarnegar et al., 2008; Hildebrand
et al., 2011), acting as a negative regulator of the non-canonical
NF-κB pathway (Yang and Sun, 2015). The accumulation of
NIK leads to IKKα activation and p100 processing to yield
p52 (Sun, 2017). We have also demonstrated that the IFN-β
promoter activation is increased when Tax-1 and TRAF3 are
co-expressed with IKKε or TBK1 (Diani et al., 2015). The impact
of TRAF3 on HTLV-mediated NF-κB activation has not yet been
understood. In the present study, we demonstrate that TRAF3
plays a critical role in Tax-mediated NF-κB activation. We further
show that APH-2, unlike HBZ, may form complexes with Tax-2
and key factors of the NF-κB signaling pathway, decreasing p65
nuclear translocation. These results can contribute to highlight
a novel regulatory mechanism of NF-κB activation mediated
by HTLV proteins.
MATERIALS AND METHODS
Cell Lines and Transfection
HeLa, HEK293T, TRAF3 knock-out (TRAF3-KO) and U2OS
cells were maintained in Dulbecco’s modified Eagle’s Medium
(DMEM) supplemented with 10% fetal calf serum (FCS),
L-glutamine (2 mM), and Penicillin G (100 U/L)/Streptomycin
(100 mcg/L). Jurkat T-cells (clone E6-1) were grown to a density
of 5 × 105 cells/mL in RPMI-1640 medium supplemented
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with 10% FCS, L-glutamine (2 mM) and Penicillin G (100
U/L)/Streptomycin (100 mcg/L). All cell lines were grown
at 37◦C in a humidified atmosphere with 5% CO2. For
immunoprecipitation and confocal analysis, 4 × 105 HEK293T
and HeLa cells were seeded in 6-well plates. For transactivation
studies, 2× 105 HEK293T cells were seeded in 12-well plates and
transfected using TransIT R©-LT1 transfection reagent (MIR2300,
Mirus Bio), following the manufacturer’s protocol. For confocal
and transactivation analysis of Jurkat cells, 2 × 106 cells were
transfected by electroporation using the Neon Transfection
System (Thermo Fisher Scientific), applying three pulsations of
10 ms at 1,325 V.
CRISPR/Cas9 Knockout of TRAF3
To induce the TRAF3 knockout, two guide RNA (gRNA)
sequences 5′-AGCCCGAAGCAGACCGAGTG-3′ and
5′-TCTTGACACGCTGTACATTT-3′ were designed to target
exon 1 and exon 2 of the TRAF3 gene, respectively. gRNAs
were selected using online tools1 (Ran et al., 2013). A third
gRNA sequence, 5′-CCAGTTTTTGTCCCTGAACA-3′ was
selected to target exon 1 of TRAF3 gene (Chen et al., 2015).
Potential off−target sites were predicted using the online tool
“CHOPCHOP”2 (Labun et al., 2016). Each selected gRNA was
cloned independently, using the T4 DNA ligase (Promega) into
the BbsI restriction sites of the pSpCas9(BB)-2A-Puro (PX459)
V2.0 vector (#62988, Addgene) and transfected in HEK293T cells
using the TransIT R©-LT1 transfection reagent (MIR2300, Mirus
Bio), following the manufacturer’s protocol. Cells were selected
using 0.5 µg/ml puromycin for 3 days after transfection. Clonal
cell lines were isolated by limiting dilution and the absence of the
TRAF3 protein was tested by western blot using an anti-TRAF3
specific antibody.
Plasmids
pJFE-Tax-1, pJFE-Tax-2B full length expression vectors and
the plasmid constructs expressing Tax-M22 and Tax-1 K1-10R
mutants have been previously described (Turci et al., 2006, 2012).
pFlag-APH-2, pGFP-APH-2, pFlag-HBZ, expression plasmids
were kindly provided by Dr. Sheehy (Marban et al., 2012).
pRSV-RelA/p65, pCMVF-TAB2 and Flag-TRAF3, HA-TRAF3
expression vectors have been previously described (Avesani et al.,
2010; Diani et al., 2015). pEF-p52 was kindly provided by Dr.
Matsuoka. pcDNA3-VSV-APH-2, pSG5M-Tax2-His, His-HBZ
have been previously described (Journo et al., 2013; Dubuisson
et al., 2018). pSpCas9(BB)-2A-Puro (PX459) V2.0 vector was
purchased from Addgene. NF-κB-Luc and phRG-TK plasmids
have been previously described (Bergamo et al., 2017).
Antibodies
The following primary antibodies were used: mouse monoclonal
anti-Flag M2 (F3165, Sigma-Aldrich), rabbit polyclonal
anti-Flag (F7425, Sigma-Aldrich), mouse monoclonal anti-VSV
(V5507, Sigma-Aldrich), rabbit polyclonal anti-VSV (V4888,
Sigma-Aldrich), goat polyclonal anti-His (ab9136, Abcam), rabbit
1http://crispr.mit.edu
2http://chopchop.cbu.uib.no/
polyclonal anti-HA (H6908, Sigma-Aldrich), mouse monoclonal
anti-HA (16B12, Covance), rabbit polyclonal anti IκB-α (#9242,
Cell Signaling), rabbit polyclonal anti-TRAF3 (18099-1-AP,
ProteinTech), mouse monoclonal anti-p65 (C-20) (sc-372, Santa
Cruz), rabbit polyclonal anti-p65 (MAB3026, Merck Millipore),
mouse monoclonal anti-IKKγ (611306, BD Bioscience), rabbit
monoclonal anti-NF-κB2 p100/p52 (#3017, Cell Signaling
Technology), mouse monoclonal anti-β-tubulin (bsm-33034M,
Bioss Antibodies), mouse monoclonal anti-Tax-1 derives from
hybridoma 168-A51 (AIDS research and Reagent Program,
National Institutes of Health), rabbit polyclonal anti-Tax-2
has been previously described (Turci et al., 2012). Horseradish
peroxidase-conjugated secondary antibodies anti-mouse IgG
(31430, Thermo Fisher Scientific) and anti-rabbit IgG (31460,
Thermo Fisher Scientific) were used in western blotting.
The secondary antibodies anti-rabbit488 (ab98488, Abcam),
anti-goat488 (ab150129, Abcam), anti-mouse549 (DI-2549,
Vector Lab), anti-goat TexasRed (705-075-147, Jackson Imm.
Res.), (ab150107, Abcam), anti-rabbit649 (STAR36D649, AbD
serotec) were used in immunofluorescence.
Co-immunoprecipitations
HEK293T cells were harvested 24 h after transfection with 1 µg
of each expression vector. Cells were lysed in non-denaturing
buffer (10 mM Tris–HCl pH 7.5, 5 mM EDTA, 150 mM NaCl, 1%
TritonX-100) supplemented with protease inhibitors Complete
Protease Inhibitor Cocktail EDTA-free (Roche). Lysates were
sonicated twice for 5 s, frozen at −80◦C for 1 h and
then centrifuged for 30 min at 14000 rpm at 4◦C. Proteins
were subjected to co-immunoprecipitation with the appropriate
primary antibodies overnight at 4◦C. Immunocomplexes were
linked to magnetic beads of Dynabeads Protein G or A
(LifeTechnologies) for 30 min at 4◦C. The beads were then
washed 3 times and resuspended in elution buffer containing
NuPAGE loading buffer (LifeTechnologies) and 0.25 mM DTT.
Western Blotting
Total protein concentration in cell lysates was determined
by Bradford Coomassie brilliant blue assay (Sigma-Aldrich).
Equal amounts of cellular proteins were resolved in SDS
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred
to a PVDF membrane (GE Healthcare). Membranes were first
saturated in TBS solution containing 5% non-fat milk and
0.1% Tween20, and then incubated with specific primary and
secondary antibodies. Anti-β-tubulin was used as loading control.
Bound antibodies were revealed using ECL prime western
blotting detection reagent (GE Healthcare), according to the
manufacturer’s instructions. Densitometry analysis of western
blot protein bands was performed using the GelQuant. NET
software provided by http://biochemlabsolutions.com.
Luciferase Reporter Assay
Luciferase functional quantitative assay was performed as
previously described (Bergamo et al., 2017). Briefly, HEK293T,
TRAF3-KO and Jurkat cells were transfected with 500 ng of
the NF-κB-Luc reporter plasmid together with the appropriate
expression vectors or an empty vector. Transfection efficiency
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was normalized using 100 ng of phRG-TK plasmid (Renilla
luciferase vector). TNF-α-induced NF-κB-activation was
analyzed following transient expression of a NF-κB-luciferase
reporter vector and cell stimulation with 25 ng/mL TNF-α for
18 h. Luciferase activity was assayed 24 h post-transfection using
the Dual-Luciferase reporter assay system (Promega). Levels of
Firefly and Renilla luciferase were measured with a 20/20n Single
Tube Luminometer (Promega). Experiments were repeated
at least three times and luciferase activity was measured after
deduction of the activity levels with the promoter alone.
Fluorescence Microscopy
HeLa, HEK293T, TRAF3-KO, U2OS and Jurkat cells were
transfected with 1 or 2 µg of each appropriate expression
vector; p65 protein nuclear translocation was analyzed following
25 ng/mL TNF-α cell stimulation for 20 min. Cells were
seeded on cover glasses and 24 h post-transfection HeLa,
HEK293T, TRAF3-KO, and U2OS cells were fixed with 4%
paraformaldehyde/PBS, whereas Jurkat cells were fixed with
formalin (HT5011, Sigma-Aldrich), for 20 min. Cells were
then permeabilized with 0.5% Triton X-100/PBS for 20 min,
blocked with a 5% milk/PBS solution and incubated with
appropriate primary and conjugated secondary antibodies.
The cover glasses were then mounted in DAPI-containing
Fluoromount-G (Southern Biotech). For confocal analyses, slides
were examined under a LSM800 (Carl Zeiss MicroImaging)
confocal microscope equipped with 63× 1.4 plan apochromat
oil-immersion objective using the ZEN software. For
epifluorescence imaging, slides were examined under an
AxioImager.Z1 microscope (Zeiss) using the Methamorph
software. To quantify p65 nuclear translocation, the ratios of the
nuclear/total p65 mean brightness staining were calculated using
ImageJ software. RGB profiles were calculated using the RGB
profiler plugin.
RNA Isolation and Quantitative
Real-Time PCR
Total RNA was extracted from HEK293T and TRAF3-KO cells
using TRIzolTM (Invitrogen), according to the manufacturers’
recommendations. RNA was quantified by NanoDrop 2000
Spectrophotometer (Thermo Fisher Scientific) and absorbance
ratio at 260/280 and 260/230 were measured. Total RNA
(1 µg) was reverse transcribed at 50◦C for 45 min using oligo
dT primers and the SuperScriptTM III First-Strand Synthesis
System (Invitrogen).
PCR reactions were performed using the Power SYBR R©
Green PCR Master Mix (Applied Biosystems) and ran on CFX
ConnectTM Real-Time Detection System (Bio-Rad). Primer pairs
for TNF Alpha Induced Protein 3 (TNFAIP3/A20), Apoptosis
Regulator Bcl-2 (BCL2), Interleukin 6 (IL-6), and Ribosomal
Protein Lateral Stalk Subunit P0 (RPLP0) gene expression
analysis are listed in Table 1. PCR cycles included an initial
step of 10 min at 95◦C required for enzyme activation, followed
by 40 cycles of amplification: denaturation for 15 s at 95◦C,
annealing and extension for 60 s at 60◦C. The relative fold change
values were calculated using the 2−11Ct method (Livak and
Schmittgen, 2001). RPLP0 was used as internal reference gene.
Statistical Analyses
All data are presented as the means± standard deviation from at
least three independent experiments. Statistical significance was
assessed by the Student’s t-test. Differences were considered to
be significant when P < 0.05 (∗), and strongly significant when
P < 0.01 (∗∗), and P < 0.001 (∗∗∗).
RESULTS
TRAF3 Is Required for an Efficient
Activation of NF-κB Mediated by Tax
It has been shown that ATL cells exhibit high expression levels
of NIK, a positive regulator of the NF-κB pathway and that
NIK turnover is regulated by protein complexes that contain
the E3 ubiquitin ligase TRAF3 (Chan and Greene, 2012).
Based on our previous data showing that TRAF3 interacts with
both Tax-1 and Tax-2 (Diani et al., 2015), we investigated the
contribution of TRAF3 in the modulation of NF-κB mediated by
the viral regulatory proteins. We produced TRAF3-KO HEK293T
cell lines introducing insertion/deletion (indel) mutations by
transfection of TRAF3 RNA-guided Cas9 nuclease expressing
plasmid. TRAF3-KO clones were first characterized for their
ability to activate an NF-κB promoter. Using the luciferase
reporter assay, we first found that in the absence of any
stimulus, the basal NF-κB promoter activity was increased
50 folds in TRAF3-KO cell lines as compared to wild type
cells (WT) (Figure 1A). The luciferase activity was restored
by the rescue of TRAF3 expression in transfected TRAF3-KO
TABLE 1 | qRT-PCR primer sequences.
Gene Accession no. Primer sequence (5′ -≥ 3′) PCR product
(pb)
TNFAIP3 (A20) NM_001270507.1 F: CTGGGACCATGGCACAACTC
R: CGGAAGGTTCCATGGGATTC
182
BCL2 NM_000633.2 F: GATGTGATGCCTCTGCGAAG
R: CATGCTGATGTCTCTGGAATCT
92
IL6 NM_000600.4 F: TACATCCTCGACGGCATCTC
R: TGGCTTGTTCCTCACTACTCT
247
RPLP0 NM_001002.4 F: ACATGTTGCTGGCCAATAAGGT
R: CCTAAAGCCTGGAAAAAGGAGG
127
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FIGURE 1 | TRAF3 is required for an efficient activation of NF-κB mediated by Tax. (A) Luciferase levels were measured from HEK293T (WT) and TRAF3-KO cells
transfected with phRG-TK renilla vector (control for transfection efficiency) and NF-κB-luciferase reporter expressing vector. (B) Luciferase levels were measured from
HEK293T (WT) and TRAF3-KO cells transfected with phRG-TK renilla vector, NF-κB-luciferase reporter and increasing amount of Flag-TRAF3 expressing vector.
(Continued)
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FIGURE 1 | Continued
(C) HEK293T (WT) and TRAF3-KO cells were lysed and immunoblot analysis was performed to compare the levels of endogenous IκB. The amount of IκB was
measured relative to the amount of β-tubulin. (D) HEK293T (WT) and TRAF3-KO cells were stained with anti-p65 (green signal) primary antibody. Nuclei were stained
with DAPI (blue signal). Scalebar, 10 µm. Total cells and nuclei of cells (n = 10) indicated by a number from 1 to 10 in white were delineated using ImageJ software,
and the mean brightness ratio of the nuclear RelA/p65 staining was calculated and presented as box-plot. (E) Immunoblot analysis of p100/p52 proteins expression
levels in HEK293T (WT) and TRAF3-KO cells. (F) HEK293T (WT) and TRAF3-KO cells were transfected with phRG-TK renilla vector, NF-κB-luciferase reporter and
p65, Tax-1, Tax-2, or TRAF3 expression plasmids. Cell lysates were collected and luciferase levels were measured. Immunoblot analysis was performed to detect of
TRAF3, p65, Tax-1 and Tax-2 (N.S. = not significant). (G) RNA from HEK293T (WT) and TRAF3-KO cells were analyzed by qRT-PCR for NF-κB-related transcripts.
The values were normalized to RPLP0 and the results were expressed as relative fold change of expression levels. (H) HEK293T (WT) and TRAF3-KO cells were
transfected with Tax-1 encoding vector and stained with anti-p65 (green signal) and anti-Tax-1 (red signal) primary antibody. Nuclei were stained with DAPI (blue
signal). Total cells and nuclei were delineated using ImageJ software, and the mean brightness ratio of the nuclear p65 staining was calculated (right
panel). Scalebar, 10 µm. P < 0.05 (∗) and P < 0.01 (∗∗).
cells (Figure 1B). The basal activation of NF-κB in TRAF3-KO
cells was further confirmed by analyzing IκB protein level. As
expected, we measured a reduced amount of IκB (30% decrease)
in TRAF3-KO cells as compared to WT cells (Figure 1C).
When the basal endogenous p65 distribution was analyzed in
TRAF3-KO cells, the presence of p65 in the nucleus, even
if limited to a weak signal, was observed (Figure 1D). The
mean brightness ratio of the nuclear p65 staining was increased
1.5 fold in the TRAF3-KO cells compared to the WT. This
indicates that the canonical NF-κB pathway is constitutively
although partially activated in the absence of TRAF3. To define
if the alternative NF-κB pathway is also activated in the absence
of TRAF3, the processing of the p100 protein was analyzed.
As shown in Figure 1E, accumulation of p52 was detectable
in the TRAF3-KO cell line, but not in the WT cells. These
results showing that the depletion of TRAF3 enables detectable
translocation of p65 into the nucleus, as well as p100 processing,
suggest that both the canonical and non-canonical NF-κB may be
partially activated.
When we analyzed the NF-κB activation induced by the
expression of p65 in TRAF3-KO cells, we unexpectedly measured
a limited induction compared to WT cells (about 9-fold
decrease). A similar dramatic reduction of NF-κB induction by
Tax-1 or Tax-2 was observed in TRAF3-KO cells compared to WT
cells (about 5-fold and 6-fold decrease, respectively) (Figure 1F).
Reconstituted TRAF3 expression restored the efficiency of
p65- and Tax-mediated activation. In order to explore the
mechanism that impairs the full activation of NF-κB mediated
by p65 in the absence of TRAF3, we analyzed TNF-α-mediated
induction of the NF-κB promoter in TRAF3-KO cells. After
TNF-α stimulation, we measured a significant NF-κB activation
in TRAF3-KO cells, although lower when compared to WT cells
(Supplementary Figure 1A). When we analyzed p65 nuclear
translocation induced by TNF-α, we observed p65 nuclear
translocation in WT and TRAF3-KO cells (Supplementary
Figure 1B), indicating that the NF-κB pathway was activated,
although the resulting transcriptional activity of p65 was reduced.
To explore the possibility that in TRAF3-KO cells the basal
activation of NF-κB may lead to the expression of NF-κB target
genes that control p65 activity by negative feedback loops, we
analyzed the expression of A20 and BCL2 genes, which are
well known negative regulators of NF-κB (Grimm et al., 1996;
Pujari et al., 2013). We found that both genes were significantly
more expressed in TRAF3-KO cells compared to WT suggesting
that limited p65-mediated induction of NF-κB in TRAF3-KO
cells can be due to negative feedback mechanisms (Figure 1G).
Furthermore, the results showed an increased expression of
IL-6, an NF-κB target gene (Libermann and Baltimore, 1990)
(Figure 1G) compared to the WT cells.
In agreement with the results showing that Tax-1 mediated
NF-κB activation is impaired in TRAF3-KO cells, we observed
that Tax-1 failed to induce endogenous p65 nuclear translocation
in transfected cells (Figure 1H). Taken together, these results
strongly suggest that NF-κB hyper-activation by Tax is strictly
dependent upon TRAF3 expression.
HBZ and APH-2 Interact With p65 and
Suppress the NF-κB Pathway
Since our results indicate that TRAF3 is involved in Tax-induced
NF-κB hyper-activation, and it is known that HBZ and APH-2
interfere with NF-κB signaling, we aimed to analyze whether the
antisense proteins might interfere with TRAF3 functions. Before
analyzing the specific interplay of HBZ and APH-2 with TRAF3,
we first aimed at precisely comparing their ability of antagonize
Tax-induced NF-κB activation.
HEK293T cells transfected with increasing amounts of Tax
proteins in the presence or absence of HBZ or APH-2 were
analyzed by luciferase assay (Figures 2A,B). As expected, when
HBZ was present together with low levels of Tax-1, the NF-κB
activation was significantly reduced (Figure 2A, lanes 2 vs. 5),
whereas no HBZ inhibitory effect was evident when Tax-1 was
expressed at high levels in transfected cells (Figure 2A, lane
3 vs. 6). APH-2 effect on Tax-mediated NF-κB activation was
then analyzed (Figure 2B). Similar to HBZ, APH-2 inhibited
Tax-2-induced NF-κB activity, but unexpectedly and unlike
Tax-1, high expression of Tax-2 did not restore the activation
of NF-κB (Figure 2B). Of note, this inhibitory effect of APH-2
was evident despite the fact that APH-2 was less expressed than
HBZ in transfected cells, as previously reported (Panfil et al.,
2016; Dubuisson et al., 2018). Because APH-2 appeared to be
more potent than HBZ in the inhibition of Tax-mediated NF-κB
activation, the effect of HBZ and APH-2 expression on the
NF-κB promoter activation mediated by p65 over-expression
was then compared in HEK293T cells. The inhibition was
statistically significant for both proteins and reached similar
levels (Figures 2C,D). The results were also reproduced in Jurkat
cells in the presence of APH-2 (Supplementary Figure 2A).
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FIGURE 2 | HBZ and APH-2 interact with p65 and suppress the NF-κB pathway. HEK293T cells were transfected with phRG-TK renilla vector, NF-κB-luciferase
reporter, Flag-HBZ and increasing amounts of Tax-1 (A) or Flag-APH-2 and increasing amounts of Tax-2 expression plasmids (B) (N.S. = not significant). HEK293T
cells were transfected with phRG-TK renilla vector, NF-κB-luciferase reporter, p65 expression plasmid, and increasing amounts of Flag-HBZ (C) or Flag-APH-2 (D)
expression vectors. Cell lysates were collected and luciferase levels were measured (Top). Immunoblot analysis was performed to detect the expression levels of the
(Continued)
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FIGURE 2 | Continued
transfected proteins (Bottom). (E,F) HEK293T cells were transfected with p65 or p52, Flag-APH-2, or Flag-HBZ expression vectors. Tagged proteins were
immunoprecipitated with an anti-Flag antibody and the presence of the p65 or p52 proteins was examined by western blot. (G) Jurkat cells were transfected with
VSV-APH-2 and Tax-2 expression vectors. Samples were stained with anti-VSV, anti-Tax-2 and anti-p65 primary antibodies to detect APH-2 (green signal), Tax-2
(red signal), and endogenous p65 (magenta signal), respectively. Total cells and nuclei were delineated using ImageJ software, and the mean brightness ratio of the
nuclear p65 staining was calculated (right panel). Values obtained in non-transfected cells were then subtracted from those for APH-2, Tax or APH-2+Tax-expressing
cells. Scalebar, 10 µm. (H) TNF-α expression was analyzed by qRT-PCR from RNA of HEK293T cells transfected with VSV-APH-2 and Tax-2. The values were
normalized to RPLP0 and the results were expressed as relative fold change of expression levels. (I–K) HEK293T and Jurkat cells were co-transfected with Flag-HBZ
and increasing amount of Tax-1 or with Flag-APH-2 and increasing amount of Tax-2. Immunoblot analysis was performed to compare the levels of endogenous IκB
in the presence of the viral regulatory proteins. The amount of IκB was measured relative to the amount of β-tubulin. P < 0.05 (∗), P < 0.01 (∗∗), and P < 0.001 (∗∗∗).
To further compare the mechanism of NF-κB inhibition by
both antisense proteins, we then analyzed the interaction of
HBZ and APH-2 with the transcription factors p65 and p52 by
immunoprecipitation. Figure 2E shows that p65 was detected
in complexes with both proteins, indicating that both antisense
proteins interact with the classical transcription factor p65.
When HBZ and APH-2 interaction with p52 was analyzed, it
revealed that HBZ was present in complex with p52, unlike
APH-2 (Figure 2F). These results suggested that HBZ and
APH-2 share the ability to form complexes with p65, but they
differ in their interaction with p52, the final effector of the
alternative NF-κB signaling. Given that p65 translocates into
the nucleus when Tax is expressed, the cellular localization of
p65 in the presence of APH-2 and/or Tax-2 was analyzed. The
results showed that endogenous p65 localized in the cytoplasm
in the presence of APH-2 (Figure 2G). Interestingly, it was
found that the co-expression of APH-2 and Tax-2 resulted in
their cytoplasmic co-localization and in the impairment of p65
nuclear translocation (5-fold decrease) (Figure 2G). The same
results were observed in U2OS cells (Supplementary Figure 2B).
We performed qRT-PCR analysis in the presence of Tax-2 and
APH-2, analyzing the expression of TNF-α as an example of an
NF-κB target gene. In the presence of APH-2 and Tax-2, TNF-α
expression was reduced more than 10-fold (Figure 2H). We
then analyzed the effect of HBZ and APH-2 on IκB degradation,
which allows p65 nuclear translocation and which is known to
be induced by Tax (Harhaj and Harhaj, 2005). As expected, the
expression of IκB was reduced to about 40% in the presence of
Tax-1 and 80% in the presence of both Tax-1 and HBZ proteins
(Figure 2I), whereas in the presence of both APH-2 and Tax-2
proteins, an increase in IκB expression was observed (Figure 2J).
A similar result was obtained in Jurkat cells (Figure 2K).
Taken together, these results suggest that while HBZ and APH-
2 both inhibit Tax- and p65-mediated NF-κB activation, they
may differ in their inhibition mechanism. APH-2 may inhibit
p65 translocation by affecting IκB degradation, thus limiting
Tax-2-mediated NF-κB activation.
APH-2 Is Recruited to Cytoplasmic
Structures in the Presence of Tax-2
To investigate how APH-2 might inhibit NF-κB activity upstream
of IκB degradation, we analyzed APH-2 subcellular localization.
Indeed, it has previously been reported that while Tax-1
does not interact with HBZ, Tax-2 does interact with APH-2
(Zhao et al., 2009; Marban et al., 2012). Given the different
cellular distribution of Tax-1 and Tax-2 (Meertens et al., 2004;
Bertazzoni et al., 2011), it is possible that HBZ and APH-2 differ
in the mechanism of NF-κB inhibition due to their differential
recruitment by host factors in subcellular compartments. To
test this hypothesis, HEK293T cells were transfected with Tax-1
or Tax-2 and Flag-HBZ or Flag-APH-2 expressing vectors, and
the presence of Tax in the immunocomplexes precipitated with
an anti-Flag antibody was analyzed (Figure 3A). The results,
as expected, confirmed that Tax-2 formed complexes with
APH-2, but no interaction of Tax-1 with HBZ was observed.
Confocal microscopy analyses in transfected HeLa cells showed
that HBZ alone localized in the nucleus and that when Tax-1
was co-expressed with HBZ, no co-localization was observed
(Figure 3B). Interestingly, the co-expression of APH-2 and Tax-2
resulted in APH-2 redistribution and its co-localization with
Tax-2 in cytoplasmic structures (Figure 3C). This result was
also reproduced in Jurkat cells (Figure 3D). To ensure that
recruitment of APH-2 in cytoplasmic structures is a property of
Tax-2 but not of Tax-1, HEK293T cells were transfected with both
APH-2 and Tax-1, or with both HBZ and Tax-2 vectors and their
intracellular localization was analyzed by fluorescent microscopy.
We observed that Tax-1 and APH-2 did not co-localize in the
cytoplasm (Supplementary Figure 3A). In the presence of HBZ,
Tax-2 was mainly distributed in the cytoplasm and HBZ in
the nucleus (Supplementary Figure 3B). Taken together, these
results suggest that HBZ and APH-2 differ in their subcellular
distribution when Tax proteins are expressed and that the
cytoplasmic co-localization occurs only in the presence of Tax-2
and APH-2. This might explain how HBZ and APH-2 differ in
the mechanism of NF-κB inhibition.
APH-2 Is Present in Cytoplasmic
Complexes With TAB2, NEMO, and Tax-2
We have previously shown that Tax-2 co-localizes in the
cytoplasm with the NF-κB pathway factors TAB2, NEMO and
p65 (Avesani et al., 2010). Given that APH-2 co-localizes with
Tax-2 in the cytoplasm, we speculated that APH-2 may be
recruited in complexes containing these NF-κB factors. To test
this hypothesis, the co-localization of APH-2 with TAB2 and
NEMO in Jurkat cells was analyzed by confocal microscopy
(Figure 4). The results showed a redistribution of TAB2 in
cytoplasmic structures in the presence of Tax-2 and APH-2.
TAB2 partially co-localized with APH-2 in the absence of
Tax-2 (Figure 4A). APH-2 co-localized with NEMO only in
the presence of Tax-2 (Figure 4B). The co-localization of
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FIGURE 3 | APH-2 is recruited to cytoplasmic structures in the presence of Tax-2. (A) HEK293T cells were transfected with Tax-1 and Flag-HBZ or Tax-2 and
Flag-APH-2 expression vectors. Tagged proteins were immunoprecipitated with an anti-Flag antibody and the presence of Tax protein was examined by western
blot. (B,C) HeLa cells were transfected with Tax-1 and Flag-HBZ or Tax-2 and GFP-APH-2 expression plasmids. Cells were stained with anti-Flag and anti-Tax-1
primary antibodies to detect HBZ (red signal) and Tax-1 (green signal), respectively; anti-Tax-2 primary antibody was used to detect Tax-2 (red signal) whereas APH-2
is fused to a GFP protein (green signal). (D) Jurkat cells were transfected with VSV-APH-2 and Tax-2 vectors. Cells were stained with anti-VSV, anti-Tax-2 primary
antibodies to detect APH-2 (green signal) and Tax-2 (red signal), respectively. Co-localization of Tax-2 signal with APH-2 signal was calculated using Mander’s
coefficient (M1 = 0.91; M2 = 0.76). Nuclei were stained with DAPI (blue signal). Enlargements are shown next to the “Merge” panel. The intensity of fluorescence
along the white line drawn on the merged images is plotted in the diagrams. Scalebar, 10 µm.
Tax-2 and APH-2 with NEMO was also reproduced in U2OS
cells (Supplementary Figure 4A). Taken together, these results
suggest that in the presence of Tax-2, APH-2 localized in the
cytoplasm with TAB2 and NEMO.
HBZ and APH-2 Interfere With TRAF3
Functions
Since the antisense proteins HBZ and APH-2 both repress
NF-κB activity, we investigated the possible recruitment of
HBZ and APH-2 in cytoplasmic complexes containing TRAF3.
We analyzed TRAF3 distribution in the presence of viral
antisense proteins by confocal microscopy in Jurkat cells. We
found that HBZ (green signal) and TRAF3 (magenta signal)
did not co-localize, whereas TRAF3 partially co-localized with
APH-2 in the cytoplasm (Figure 5A). We confirmed that
TRAF3 is present in immunocomplexes containing APH-2 by
co-immunoprecipitation (Figure 5B). Furthermore, we detected
TRAF3 in complexes containing both APH-2 and Tax-2
(Figure 5B). We analyzed by confocal microscopy TRAF3
distribution in the presence of APH-2 and Tax-2, and we
found that APH-2 (green signal), TRAF3 (magenta signal) and
Tax-2 (red signal) co-localized in the cytoplasm (Figure 5C).
Co-localization of Tax-2 and APH-2 with TRAF3 was also
observed in U2OS cells (Supplementary Figure 4B). This
indicates that APH-2, but not HBZ, could modulate Tax-2
induced NF-κB activation by associating with Tax-2 and
TRAF3 complexes.
To assess whether HBZ may deregulate the NF-κB pathway
by affecting the expression of TRAF3, as it was previously
shown with p65, HEK293T cells were transfected with increasing
amounts of HBZ and the expression levels of TRAF3 was
evaluated. The results demonstrated a reduction of the expression
of TRAF3 protein in the presence of HBZ and APH-2
(Figure 5D). A reduced expression of endogenous TRAF3 was
also found in the presence of increasing amounts of HBZ and
APH-2 (Supplementary Figures 5A,B). These results suggest
that TRAF3 may be involved in the mechanisms of NF-κB
deregulation mediated by HTLV proteins and that its expression
may be altered by both HBZ and APH-2 proteins.
DISCUSSION
Dysregulation of the NF-κB pathway can induce alterations of
physiological cellular responses and can lead to oncogenesis (Park
and Hong, 2016). It has been demonstrated that persistent NF-κB
activation derived from Tax expression induces cell senescence,
and the inhibitory effect of the antisense protein HBZ on NF-κB
may represent an adaptation of HTLV-1 that contributes to
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FIGURE 4 | APH-2 is present in cytoplasmic complexes with TAB2, NEMO, and Tax-2. Jurkat cells were transfected with VSV-APH-2, Tax-2 and Flag-TAB2
expression vectors. Samples were stained with anti-VSV, anti-Tax-2, anti-Flag and anti-NEMO primary antibodies to detect APH-2 (green signal), Tax-2 (red signal),
TAB2 (magenta signal), and NEMO (magenta signal), respectively (A,B). Nuclei were stained with DAPI (cyan signal). The intensity of fluorescence overlapping the
white line drawn on the merged images is plotted in the diagrams. Scalebar, 10 µm.
viral persistence and, in the long term, to ATL development
(Giam and Semmes, 2016). It has also been reported that the
inhibition of the NF-κB pathway results in the induction of
apoptosis of ATL cells (Watanabe et al., 2005). The HTLV
regulatory proteins interaction with canonical NF-κB factors
leading to NF-κB dysregulation has been intensively investigated,
but limited information is available about the interaction with
factors that play a critical role in the non-canonical pathway
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FIGURE 5 | HBZ and APH-2 interfere with TRAF3 functions. (A) Jurkat cells were transfected with Flag-HBZ or VSV-APH-2 expression vectors. Samples were
stained with an anti-TRAF3 and anti-Flag or anti-VSV primary antibodies to detect TRAF3 (magenta signal) and HBZ or APH-2 (green signal), respectively. (B)
HEK293T cells were transfected with HA-TRAF3, Tax-2 and Flag-APH-2 expression vectors. Tagged proteins were immunoprecipitated with an anti-Flag antibody
and the presence of the TRAF3 protein was examined with an anti-HA primary antibody, by western blot. (C) Jurkat cells were transfected with VSV-APH-2 and
Tax-2 expression vectors. Samples were stained with anti-VSV, anti-Tax-2 and anti-HA primary antibodies to detect APH-2 (green signal), Tax-2 (red signal), and
TRAF3 (magenta signal), respectively. Nuclei were stained with DAPI (cyan signal). The intensity of fluorescence overlapping the white line drawn on the merged
images is plotted in the diagrams. Enlargements are shown bottom the “Merge” panel. Scale bar, 10 µm. (D) HEK293T were co-transfected with HA-TRAF3 and
increasing amount of Flag-HBZ or Flag-APH-2. Immunoblot analysis (top) was performed and the amount of TRAF3, HBZ and APH-2 was measured relative to the
amount of β-tubulin (bottom).
(Schmitz et al., 2014; Fochi et al., 2018). We focused our attention
on TRAF3, a ubiquitin ligase that controls the expression levels
of the NIK kinase and that has been demonstrated to be
abnormally expressed in freshly isolated ATL cells (Watanabe,
2017). TRAF3-deficient mice display increased non-canonical
NF-κB activation as well as increased B cell survival, suggesting
that TRAF3 may act as a negative regulator of the NF-κB signaling
in vivo (Gardam et al., 2008). It has been demonstrated that
TRAF3 knockout results in NIK stabilization, inducing p100
processing (Liao et al., 2004; He et al., 2006). In TRAF3-deficient
cell lines, we found that the NF-κB pathway is activated and
that both a partial nuclear distribution of the transcriptional
factor p65 and p100 processing are taking place. These results
confirm that TRAF3 is a negative regulator of the NF-κB
pathway, but it may also participate to the functional regulation
between the two NF-κB pathways. We also found that p65 and
TNF-α partially induced NF-κB activation in TRAF3-KO cell
lines. This effect may be explained by negative feedback loop
mechanisms derived by the expression of NF-κB target genes
acting as negative regulators. This hypothesis is supported by
the qRT-PCR analyses of A20 and BCL-2 genes in TRAF3-KO
cells, showing that they are over-expressed as compared to
WT cells. It is known that A20 mediates a negative regulation
of the canonical NF-κB pathway (Pujari et al., 2013) and
BCL-2 overexpression specifically represses NF-κB-dependent
transactivation by attenuating the transactivation potential
of p65 (Grimm et al., 1996). These results are consistent
with previous data showing that TRAF3 depletion causes an
accumulation of distinct subsets of NF-κB inhibitors, including
A20 (Bista et al., 2010).
We have previously shown that Tax interacts with TRAF3
and here we demonstrate for the first time that the TRAF3
factor is required for an efficient NF-κB activation by both
Tax-1 and Tax-2.
Unlike Tax-1, Tax-2 cannot induce p100 processing to p52, but
can activate the canonical NF-κB pathway as well as Tax-1 (Xiao
et al., 2001; Higuchi et al., 2007). We found that Tax-mediated
activation of NF-κB is impaired in TRAF3-deficient cells and
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that it is restored only after rescuing TRAF3 expression.
A similar essential role of TRAF3 has been demonstrated for
the Epstein-Barr virus-encoded oncoprotein latent membrane
protein 1 (LMP1). In fact, LMP1 alone can transform rodent
fibroblasts and activate NF-κB (Cahir McFarland et al., 1999),
but in the absence of TRAF3, LMP1-induced activation of JNK,
p38, and NF-κB are impaired (Xie et al., 2004). It has been
also demonstrated that the vFlip protein expressed by Kaposi’s
sarcoma-associated herpesvirus (KSHV/HHV8) activates NF-κB
interacting with the IKK complex and the TRAF2/3 complex
(Field et al., 2003). Interestingly, we found that TRAF3 is
required not only for Tax-1, but also for Tax-2 NF-κB activation,
supporting a mechanism in which TRAF3 may be involved in
the association with factors that cooperate in the canonical and
non-canonical NF-κB pathway.
We report here a reduction of TRAF3 expression in the
presence of the antisense proteins. We would have expected an
activation of the non-canonical NF-κB pathway, but we have not
observed an accumulation of p52 in the presence of HBZ (data
not shown). This result is in agreement with data demonstrating
a lowered expression of p100 in the presence of HBZ that leads
to lowered amounts of the non-canonical transcription factor
p52 (Zhi et al., 2011). The HBZ effect in the non-canonical
NF-κB activation still remains controversial since Zhao et al.
(2009) suggest that HBZ inhibits selectively the canonical NF-κB
pathway in the presence of Tax-1.
Zhao et al. (2009) and Panfil et al. (2016) demonstrated
that both HBZ and APH-2 interact with p65 and reduce
p65-mediated NF-κB promoter activity. We show here that
HBZ and APH-2 may exert a different molecular mechanism
in the down-modulation of the NF-κB pathway. We found
that HBZ is less efficient in dampening Tax-mediated NF-κB
activity compared to APH-2 and that co-expression of HBZ
and high levels of Tax-1 results in restoring NF-κB activation,
whereas APH-2 maintains its inhibitory effect despite high
expression levels of Tax-2. We also observed that APH-2 inhibits
p65-induced NF-κB activation in both HEK293T and Jurkat
cell models. This is in contrast to the previous report showing
that APH-2 inhibits the p65-induced NF-κB activation only
in HEK293T cells (Panfil et al., 2016). This discrepancy may
be due to differences in the efficiency of cell transfection, as
declared by the authors.
By analyzing the subcellular distribution of the protein
complexes formed by Tax and the host interacting proteins,
we observed that APH-2, but not HBZ, is recruited in the
cytoplasmic structures containing NEMO and TAB2. We have
also demonstrated that the co-expression of Tax-2 and APH-2
results in the accumulation of the NF-κB inhibitor IκB and in
a partial impairment of p65 nuclear translocation, whereas IκB
expression is reduced when Tax-1 and HBZ are co-expressed.
From the results obtained, we propose a model in which the
recruitment of HBZ and APH-2 within the protein complexes
formed by Tax follows different patterns. While APH-2 is
partially retained in the cytoplasmic compartments, HBZ
translocates more efficiently into the nucleus, thus inhibiting
the transcription factor activity of p65 (Figure 6). This model
is also supported by the results of Marban et al. (2012)
that demonstrate a redistribution of APH-2 in the cytoplasm
in the presence of Tax-2, preventing APH-2 from activating
AP-1 transcription.
Our results clearly demonstrate that TRAF3 is required
for NF-κB dysregulation mediated by Tax, thus representing
a novel factor recruited by the viral regulatory proteins to
alter cell pathways. In fact, TRAF3 not only acts on NF-κB
pathway, but also plays significant roles in the immunity-related
signal transduction (Häcker et al., 2011). Cells lacking TRAF3
are defective in IFN-I responses activated by different TLRs
(Oganesyan et al., 2006). The induction of IFN-I elicits the
FIGURE 6 | Molecular model for HTLV-1 and HTLV-2 regulatory proteins HBZ and APH-2 on Tax-mediated NF-κB activation and TRAF3 interaction. In the presence
of Tax-1, HBZ inhibits p65 action in the nucleus competing with Tax-1. The recruitment of APH-2 in Tax-2-cytoplasmic complexes containing TRAF3 limits the p65
nuclear translocation.
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activation of the antiviral cellular gene expression that coincides
with the inhibition of viral replication. The key role of TRAF3
in promoting antiviral signaling is supported by a recent
study demonstrating that the deletion of TRAF3 in adult
mice attenuated their host defense against vesicular stomatitis
virus (VSV) infection (Xie et al., 2019). In the non-canonical
NF-κB pathway, TRAF3, in concert with TRAF2, cIAP1 and
cIAP2, promotes the constitutive degradation of NIK that in
turn serves as negative regulator of IFN (Jin et al., 2014;
Parvatiyar et al., 2018). A feedback inhibition mechanism has
been also proposed to induce TRAF3 degradation, affecting IFN
production and NIK accumulation (Nakhaei et al., 2009). Recent
evidence demonstrates that the HTLV antisense proteins interact
with IRF-1, a transcriptional regulator of IFN-I pathway. In
particular, APH-2 enhances IRF-1 DNA binding and steady-state
expression levels, whereas HBZ interacts with IRF-1 and
causes its degradation (Panfil et al., 2016). The loss of IRF-1
expression has been observed in several cases of leukemia
(Alsamman and El-Masry, 2018). It is reasonable to think
that the recruitment of APH-2 and Tax-2 in complexes with
TRAF3 may positively affect IFN response. This hypothesis
could be linked to the demonstration that in rabbits, the lack
of APH-2 increases the infection rate of HTLV-2 mutants
in comparison to HTLV-2 WT (Yin et al., 2012). Further
studies will be required to analyze the interplay of TRAF3
and the HTLV antisense proteins in deregulating the type
I IFN induction.
CONCLUSION
In summary, we demonstrated that TRAF3 cell factor is required
for Tax-mediated NF-κB activation. Our findings allow to further
understand the roles of host factors that may be targeted
by HTLV regulatory proteins and participate in the crosstalk
between IFN and NF-κB pathway. We also found that APH-2
is more effective than HBZ in the inhibition of Tax-mediated
NF-κB activation. We suggest that the recruitment of APH-2
in Tax-2-cytoplasmic structures with NF-κB factors that affect
the p65 nuclear translocation may explain the different effects of
APH-2 and HBZ. This work allows to shed light on the role of
HTLV-induced NF-κB pathway activation and ultimately in the
identification of potential therapeutic targets.
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